Alpha 2.0
Login Register
» Authors » Anna Condylios

Anna Condylios

Explore the profile of Anna Condylios including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 140
Followers 0
Related Specialties
Biomedical Engineering
Pediatrics
Microbiology
Top 10 Co-Authors
Anthony D Kelleher
Malinna Yeang
Anupriya Aggarwal
Gail Matthews
Stuart G Turville
Thomas Hauser
Nathan Roth
William D Rawlinson
Mariana Ruiz Silva
Thomas Barnes
Published In
EBioMedicine
Viruses
Pediatrics
Pathology
Affiliations
Soon will be listed here.
Recent Articles
1.
Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic
Akerman A, Fichter C, Milogiannakis V, Esneau C, Silva M, Ison T, et al.
EBioMedicine . 2024 Nov; 110:105415. PMID: 39549677
Background: Continued phenotyping and ongoing molecular epidemiology are important in current and future monitoring of emerging SARS-CoV-2 lineages. Herein we developed pragmatic strategies to track the emergence, spread and phenotype...
2.
Clinical, Genomic, and Immunological Characterization of RSV Surge in Sydney, Australia, 2022
Walker G, Foster C, Sevendal A, Domazetovska A, Kamalakkannan A, Williams P, et al.
Pediatrics . 2024 Jan; 153(2). PMID: 38225912
Objectives: The 2022 seasonal respiratory syncytial virus (RSV) epidemic in Sydney, Australia saw an unprecedented number of RSV detections. We aimed to characterize genomic and immunologic factors associated with the...
3.
Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
Akerman A, Milogiannakis V, Jean T, Esneau C, Silva M, Ison T, et al.
EBioMedicine . 2023 Apr; 90:104545. PMID: 37002990
Background: The Omicron era of the COVID-19 pandemic commenced at the beginning of 2022 and whilst it started with primarily BA.1, it was latter dominated by BA.2 and the related...
4.
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
Aggarwal A, Akerman A, Milogiannakis V, Silva M, Walker G, Stella A, et al.
EBioMedicine . 2022 Sep; 84:104270. PMID: 36130476
Background: Genetically distinct viral variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been recorded since January 2020. The introduction of global vaccine programs has contributed to lower COVID-19...
5.
Analysis of SARS-CoV-2 real-time PCR test CT values across a population may afford useful information to assist public health efforts and add refinement to epidemiological models
Stevens R, Pratama R, Naing Z, Condylios A
Pathology . 2022 Aug; 54(6):800-802. PMID: 35989104
No abstract available.
6.
Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing
van Bockel D, Munier C, Turville S, Badman S, Walker G, Stella A, et al.
Viruses . 2020 Oct; 12(11). PMID: 33114233
Critical to facilitating SARS-CoV-2 point-of-care (POC) testing is assurance that viruses present in specimens are inactivated onsite prior to processing. Here, we conducted experiments to determine the virucidal activity of...